The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Typhoid Vaccine Market Research Report 2024
Synopsis
Global Oral Typhoid Vaccine market is projected to reach US$ 47 million in 2029, increasing from US$ 35 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Typhoid Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Typhoid Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Berna Biotech
Emergent BioSolutions
Segment by Type
Live-attenuated Vaccine
Live Vaccine
Segment by Application
Adults
Children
Elderly
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Typhoid Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Oral Typhoid Vaccine market is projected to reach US$ 47 million in 2029, increasing from US$ 35 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Typhoid Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Typhoid Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Berna Biotech
Emergent BioSolutions
Segment by Type
Live-attenuated Vaccine
Live Vaccine
Segment by Application
Adults
Children
Elderly
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Typhoid Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oral Typhoid Vaccine Market Overview
1.1 Product Overview and Scope of Oral Typhoid Vaccine
1.2 Oral Typhoid Vaccine Segment by Type
1.2.1 Global Oral Typhoid Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Live-attenuated Vaccine
1.2.3 Live Vaccine
1.3 Oral Typhoid Vaccine Segment by Application
1.3.1 Global Oral Typhoid Vaccine Market Value by Application: (2023-2029)
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Oral Typhoid Vaccine Market Size Estimates and Forecasts
1.4.1 Global Oral Typhoid Vaccine Revenue 2018-2029
1.4.2 Global Oral Typhoid Vaccine Sales 2018-2029
1.4.3 Global Oral Typhoid Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Typhoid Vaccine Market Competition by Manufacturers
2.1 Global Oral Typhoid Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Typhoid Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Typhoid Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Oral Typhoid Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Typhoid Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Typhoid Vaccine, Product Type & Application
2.7 Oral Typhoid Vaccine Market Competitive Situation and Trends
2.7.1 Oral Typhoid Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Typhoid Vaccine Players Market Share by Revenue
2.7.3 Global Oral Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Typhoid Vaccine Retrospective Market Scenario by Region
3.1 Global Oral Typhoid Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Typhoid Vaccine Global Oral Typhoid Vaccine Sales by Region: 2018-2029
3.2.1 Global Oral Typhoid Vaccine Sales by Region: 2018-2023
3.2.2 Global Oral Typhoid Vaccine Sales by Region: 2024-2029
3.3 Global Oral Typhoid Vaccine Global Oral Typhoid Vaccine Revenue by Region: 2018-2029
3.3.1 Global Oral Typhoid Vaccine Revenue by Region: 2018-2023
3.3.2 Global Oral Typhoid Vaccine Revenue by Region: 2024-2029
3.4 North America Oral Typhoid Vaccine Market Facts & Figures by Country
3.4.1 North America Oral Typhoid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Typhoid Vaccine Sales by Country (2018-2029)
3.4.3 North America Oral Typhoid Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Typhoid Vaccine Market Facts & Figures by Country
3.5.1 Europe Oral Typhoid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Typhoid Vaccine Sales by Country (2018-2029)
3.5.3 Europe Oral Typhoid Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Typhoid Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Typhoid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Typhoid Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Typhoid Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Typhoid Vaccine Market Facts & Figures by Country
3.7.1 Latin America Oral Typhoid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Typhoid Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Oral Typhoid Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Typhoid Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Typhoid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Typhoid Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Typhoid Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Typhoid Vaccine Sales by Type (2018-2029)
4.1.1 Global Oral Typhoid Vaccine Sales by Type (2018-2023)
4.1.2 Global Oral Typhoid Vaccine Sales by Type (2024-2029)
4.1.3 Global Oral Typhoid Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Oral Typhoid Vaccine Revenue by Type (2018-2029)
4.2.1 Global Oral Typhoid Vaccine Revenue by Type (2018-2023)
4.2.2 Global Oral Typhoid Vaccine Revenue by Type (2024-2029)
4.2.3 Global Oral Typhoid Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Oral Typhoid Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Typhoid Vaccine Sales by Application (2018-2029)
5.1.1 Global Oral Typhoid Vaccine Sales by Application (2018-2023)
5.1.2 Global Oral Typhoid Vaccine Sales by Application (2024-2029)
5.1.3 Global Oral Typhoid Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Oral Typhoid Vaccine Revenue by Application (2018-2029)
5.2.1 Global Oral Typhoid Vaccine Revenue by Application (2018-2023)
5.2.2 Global Oral Typhoid Vaccine Revenue by Application (2024-2029)
5.2.3 Global Oral Typhoid Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Oral Typhoid Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Berna Biotech
6.1.1 Berna Biotech Corporation Information
6.1.2 Berna Biotech Description and Business Overview
6.1.3 Berna Biotech Oral Typhoid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Berna Biotech Oral Typhoid Vaccine Product Portfolio
6.1.5 Berna Biotech Recent Developments/Updates
6.2 Emergent BioSolutions
6.2.1 Emergent BioSolutions Corporation Information
6.2.2 Emergent BioSolutions Description and Business Overview
6.2.3 Emergent BioSolutions Oral Typhoid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Emergent BioSolutions Oral Typhoid Vaccine Product Portfolio
6.2.5 Emergent BioSolutions Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Typhoid Vaccine Industry Chain Analysis
7.2 Oral Typhoid Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Typhoid Vaccine Production Mode & Process
7.4 Oral Typhoid Vaccine Sales and Marketing
7.4.1 Oral Typhoid Vaccine Sales Channels
7.4.2 Oral Typhoid Vaccine Distributors
7.5 Oral Typhoid Vaccine Customers
8 Oral Typhoid Vaccine Market Dynamics
8.1 Oral Typhoid Vaccine Industry Trends
8.2 Oral Typhoid Vaccine Market Drivers
8.3 Oral Typhoid Vaccine Market Challenges
8.4 Oral Typhoid Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
